ID FGFR3_CHICK Reviewed; 806 AA. AC P18460; DT 01-NOV-1990, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1990, sequence version 1. DT 02-SEP-2026, entry version 171. DE RecName: Full=Fibroblast growth factor receptor 3; DE Short=FGFR-3; DE EC=2.7.10.1; DE AltName: Full=Tyrosine kinase receptor CEK2; DE Flags: Precursor; GN Name=FGFR3; Synonyms=CEK2; OS Gallus gallus (Chicken). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; OC Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; OC Phasianinae; Gallus. OX NCBI_TaxID=9031; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2165604; DOI=10.1073/pnas.87.15.5812; RA Pasquale E.B.; RT "A distinctive family of embryonic protein-tyrosine kinase receptors."; RL Proc. Natl. Acad. Sci. U.S.A. 87:5812-5816(1990). CC -!- FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor CC for fibroblast growth factors and plays an essential role in the CC regulation of cell proliferation, differentiation and apoptosis. Plays CC an essential role in the regulation of chondrocyte differentiation, CC proliferation and apoptosis, and is required for normal skeleton CC development. Regulates both osteogenesis and postnatal bone CC mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but CC can also promote cancer cell proliferation. Phosphorylates PLCG1, CBL CC and FRS2. Ligand binding leads to the activation of several signaling CC cascades. Activation of PLCG1 leads to the production of the cellular CC signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. CC Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and CC SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the CC MAP kinase signaling pathway, as well as of the AKT1 signaling pathway CC (By similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + CC ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA- CC COMP:20101, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, CC ChEBI:CHEBI:61978, ChEBI:CHEBI:456216; EC=2.7.10.1; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10028}; CC -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence CC of bound ligand. Ligand binding leads to dimerization and activation by CC autophosphorylation on tyrosine residues (By similarity). CC {ECO:0000250}. CC -!- SUBUNIT: Monomer. Homodimer after ligand binding (By similarity). CC {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I CC membrane protein {ECO:0000250}. CC -!- DOMAIN: The second and third Ig-like domains directly interact with CC fibroblast growth factors (FGF) and heparan sulfate proteoglycans. CC {ECO:0000250}. CC -!- PTM: Autophosphorylated. Binding of FGF family members together with CC heparan sulfate proteoglycan or heparin promotes receptor dimerization CC and autophosphorylation on tyrosine residues. Autophosphorylation CC occurs in trans between the two FGFR molecules present in the dimer (By CC similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein CC kinase family. Fibroblast growth factor receptor subfamily. CC {ECO:0000255|PROSITE-ProRule:PRU00159}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M35195; AAA48664.1; -; mRNA. DR PIR; A35963; A35963. DR RefSeq; NP_990840.2; NM_205509.3. DR AlphaFoldDB; P18460; -. DR SMR; P18460; -. DR FunCoup; P18460; 471. DR STRING; 9031.ENSGALP00000001710; -. DR GlyCosmos; P18460; 8 sites, No reported glycans. DR GlyGen; P18460; 8 sites. DR PaxDb; 9031-ENSGALP00000001710; -. DR GeneID; 396515; -. DR KEGG; gga:396515; -. DR CTD; 2261; -. DR VEuPathDB; HostDB:geneid_396515; -. DR eggNOG; KOG0200; Eukaryota. DR InParanoid; P18460; -. DR OrthoDB; 5984265at2759; -. DR PhylomeDB; P18460; -. DR BRENDA; 2.7.10.1; 1306. DR PRO; PR:P18460; -. DR Proteomes; UP000000539; Chromosome 4. DR Bgee; ENSGALG00000015708; Expressed in ovary and 10 other cell types or tissues. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0043235; C:signaling receptor complex; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; IEA:InterPro. DR GO; GO:0017134; F:fibroblast growth factor binding; IBA:GO_Central. DR GO; GO:0005007; F:fibroblast growth factor receptor activity; IBA:GO_Central. DR GO; GO:0048513; P:animal organ development; IEA:UniProtKB-ARBA. DR GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-ARBA. DR GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IBA:GO_Central. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IBA:GO_Central. DR GO; GO:0043410; P:positive regulation of MAPK cascade; IBA:GO_Central. DR CDD; cd05857; IgI_2_FGFR; 1. DR CDD; cd05858; IgI_3_FGFR2; 1. DR CDD; cd05100; PTKc_FGFR3; 1. DR FunFam; 1.10.510.10:FF:000007; Fibroblast growth factor receptor; 1. DR FunFam; 2.60.40.10:FF:000016; Fibroblast growth factor receptor; 1. DR FunFam; 2.60.40.10:FF:000020; Fibroblast growth factor receptor; 1. DR FunFam; 2.60.40.10:FF:000423; Fibroblast growth factor receptor; 1. DR FunFam; 3.30.200.20:FF:000011; Fibroblast growth factor receptor; 1. DR Gene3D; 6.10.250.1740; -; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 3. DR Gene3D; 3.30.200.20; Phosphorylase Kinase, domain 1; 1. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR016248; FGF_rcpt_fam. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR013098; Ig_I-set. DR InterPro; IPR003599; Ig_sub. DR InterPro; IPR003598; Ig_sub2. DR InterPro; IPR013151; Immunoglobulin_dom. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR017441; Protein_kinase_ATP_BS. DR InterPro; IPR050122; RTK. DR InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom. DR InterPro; IPR008266; Tyr_kinase_AS. DR InterPro; IPR020635; Tyr_kinase_cat_dom. DR PANTHER; PTHR24416:SF505; FIBROBLAST GROWTH FACTOR RECEPTOR 3; 1. DR PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1. DR Pfam; PF21165; FGFR3_TM; 1. DR Pfam; PF07679; I-set; 1. DR Pfam; PF00047; ig; 1. DR Pfam; PF13927; Ig_3; 1. DR Pfam; PF07714; PK_Tyr_Ser-Thr; 1. DR PIRSF; PIRSF000628; FGFR; 1. DR PRINTS; PR00109; TYRKINASE. DR SMART; SM00409; IG; 3. DR SMART; SM00408; IGc2; 3. DR SMART; SM00219; TyrKc; 1. DR SUPFAM; SSF48726; Immunoglobulin; 3. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS50835; IG_LIKE; 3. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS00109; PROTEIN_KINASE_TYR; 1. PE 2: Evidence at transcript level; KW Apoptosis; ATP-binding; Cell membrane; Disulfide bond; Glycoprotein; KW Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding; KW Phosphoprotein; Receptor; Reference proteome; Repeat; Signal; Transferase; KW Transmembrane; Transmembrane helix; Tyrosine-protein kinase. FT SIGNAL 1..19 FT /evidence="ECO:0000255" FT CHAIN 20..806 FT /note="Fibroblast growth factor receptor 3" FT /id="PRO_0000016790" FT TOPO_DOM 20..364 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 365..389 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 390..806 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 24..124 FT /note="Ig-like C2-type 1" FT DOMAIN 150..238 FT /note="Ig-like C2-type 2" FT DOMAIN 247..349 FT /note="Ig-like C2-type 3" FT DOMAIN 466..755 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT REGION 121..146 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 130..141 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 611 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159, FT ECO:0000255|PROSITE-ProRule:PRU10028" FT BINDING 472..480 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 502 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT MOD_RES 641 FT /note="Phosphotyrosine; by autocatalysis" FT /evidence="ECO:0000250" FT MOD_RES 642 FT /note="Phosphotyrosine; by autocatalysis" FT /evidence="ECO:0000250" FT MOD_RES 718 FT /note="Phosphotyrosine; by autocatalysis" FT /evidence="ECO:0000250" FT MOD_RES 754 FT /note="Phosphotyrosine; by autocatalysis" FT /evidence="ECO:0000250" FT CARBOHYD 83 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 96 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 118 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 219 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 256 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 288 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 309 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 322 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 61..107 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 170..222 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 269..333 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" SQ SEQUENCE 806 AA; 89730 MW; B38B3C6D5F2314B6 CRC64; MRAAWGSVWC LCLAAAVGAL PAARRRGAER SGGQAAEYLR SETAFLEELV FGSGDTIELS CNTQSSSVSV FWFKDGIGIA PSNRTHIGQK LLKIINVSYD DSGLYSCKPR HSNEVLGNFT VRVTDSPSSG DDEDDDDESE DTGVPFWTRP DKMEKKLLAV PAANTVRFRC PAGGNPTPTI YWLKNGKEFK GEHRIGGIKL RHQQWSLVME SVVPSDRGNY TCVVENKYGN IRHTYQLDVL ERSPHRPILQ AGLPANQTVV VGSNVEFHCK VYSDAQPHIQ WLKHVEVNGS KYGPDGTPYV TVLKTAGVNT TDKELEILYL RNVTFEDAGE YTCLAGNSIG FSHHSAWLTV LPAEELMEMD DSGSVYAGIL SYGTGLVLFI LVLVIVIICR MKMPNKKAMN TTTVQKVSKF PLKRQQVSLE SNSSMNSNTP LVRITRLSSS DGPMLANVSE LELPPDPKWE LARSRLTLGK PLGEGCFGQV VMAEAIGIDK DKPNKAITVA VKMLKDDATD KDLSDLVSEM EMMKMIGKHK NIINLLGACT QDGPLYVLVE YASKGNLREY LRARRPPGMD YSFDTCKLPE EQLTFKDLVS CAYQVARGME YLASQKCIHR DLAARNVLVT EDNVMKIADF GLARDVHNID YYKKTTNGRL PVKWMAPEAL FDRVYTHQSD VWSFGVLLWE IFTLGGSPYP GIPVEELFKL LKEGHRMDKP ANCTHDLYMI MRECWHAVPS QRPTFKQLVE DLDRVLTMTS TDEYLDLSVP FEQYSPAGQD THSTCSSGDD SVFAHDLLPD EPCLPKHVPC NGVIRT //